• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对超过 10000 株 SARS-CoV-2 病毒进行全基因组分析揭示了全球遗传多样性和 NSP6 的靶标区域。

Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.

机构信息

Department of Computer Science and Engineering, National Institute of Technical Teachers' Training and Research, Kolkata, West Bengal, India.

Department of Computer Science and Information Technology, Institute of Technical Education and Research, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.

出版信息

Brief Bioinform. 2021 Mar 22;22(2):1106-1121. doi: 10.1093/bib/bbab025.

DOI:10.1093/bib/bbab025
PMID:33725111
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7989641/
Abstract

Whole genome analysis of SARS-CoV-2 is important to identify its genetic diversity. Moreover, accurate detection of SARS-CoV-2 is required for its correct diagnosis. To address these, first we have analysed publicly available 10 664 complete or near-complete SARS-CoV-2 genomes of 73 countries globally to find mutation points in the coding regions as substitution, deletion, insertion and single nucleotide polymorphism (SNP) globally and country wise. In this regard, multiple sequence alignment is performed in the presence of reference sequence from NCBI. Once the alignment is done, a consensus sequence is build to analyse each genomic sequence to identify the unique mutation points as substitutions, deletions, insertions and SNPs globally, thereby resulting in 7209, 11700, 119 and 53 such mutation points respectively. Second, in such categories, unique mutations for individual countries are determined with respect to other 72 countries. In case of India, unique 385, 867, 1 and 11 substitutions, deletions, insertions and SNPs are present in 566 SARS-CoV-2 genomes while 458, 1343, 8 and 52 mutation points in such categories are common with other countries. In majority (above 10%) of virus population, the most frequent and common mutation points between global excluding India and India are L37F, P323L, F506L, S507G, D614G and Q57H in NSP6, RdRp, Exon, Spike and ORF3a respectively. While for India, the other most frequent mutation points are T1198K, A97V, T315N and P13L in NSP3, RdRp, Spike and ORF8 respectively. These mutations are further visualised in protein structures and phylogenetic analysis has been done to show the diversity in virus genomes. Third, a web application is provided for searching mutation points globally and country wise. Finally, we have identified the potential conserved region as target that belongs to the coding region of ORF1ab, specifically to the NSP6 gene. Subsequently, we have provided the primers and probes using that conserved region so that it can be used for detecting SARS-CoV-2. Contact:indrajit@nitttrkol.ac.inSupplementary information: Supplementary data are available at http://www.nitttrkol.ac.in/indrajit/projects/COVID-Mutation-10K.

摘要

对 SARS-CoV-2 进行全基因组分析对于确定其遗传多样性很重要。此外,还需要准确检测 SARS-CoV-2 以进行正确诊断。为此,我们首先分析了全球 73 个国家/地区公开的 10664 个完整或近乎完整的 SARS-CoV-2 基因组,以在全球和国家范围内发现编码区域中的突变点,如替换、缺失、插入和单核苷酸多态性(SNP)。在这方面,在参考来自 NCBI 的序列的情况下进行多序列比对。完成比对后,构建共识序列以分析每个基因组序列,以在全球范围内识别替换、缺失、插入和 SNP 等独特的突变点,从而分别得到 7209、11700、119 和 53 个这样的突变点。其次,在这些类别中,确定了针对其他 72 个国家/地区的各个国家/地区的独特突变。就印度而言,在 566 个 SARS-CoV-2 基因组中存在 385、867、1 和 11 个独特的替换、缺失、插入和 SNP,而在这些类别中与其他国家/地区共有的 458、1343、8 和 52 个突变点。在病毒种群的大多数(超过 10%)中,在全球(不包括印度)和印度之间的最常见和最常见的突变点是 NSP6、RdRp、Exon、Spike 和 ORF3a 中的 L37F、P323L、F506L、S507G、D614G 和 Q57H。而对于印度,其他最常见的突变点是 NSP3、RdRp、Spike 和 ORF8 中的 T1198K、A97V、T315N 和 P13L。这些突变在蛋白质结构中进一步可视化,并进行了系统发育分析以显示病毒基因组的多样性。第三,提供了一个用于在全球和国家范围内搜索突变点的网络应用程序。最后,我们确定了作为 ORF1ab 编码区的靶标,特别是 NSP6 基因的潜在保守区域。随后,我们使用该保守区域提供了引物和探针,以便可以用于检测 SARS-CoV-2。联系人:indrajit@nitttrkol.ac.in 附加信息:补充数据可在 http://www.nitttrkol.ac.in/indrajit/projects/COVID-Mutation-10K 获得。

相似文献

1
Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.对超过 10000 株 SARS-CoV-2 病毒进行全基因组分析揭示了全球遗传多样性和 NSP6 的靶标区域。
Brief Bioinform. 2021 Mar 22;22(2):1106-1121. doi: 10.1093/bib/bbab025.
2
Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.全球 SARS-CoV-2 蛋白质组的变异及其对 5 种主要 SARS-CoV-2 谱系在封锁前出现和传播的影响。
Infect Genet Evol. 2021 Sep;93:104973. doi: 10.1016/j.meegid.2021.104973. Epub 2021 Jun 18.
3
Genome-wide analysis of Indian SARS-CoV-2 genomes for the identification of genetic mutation and SNP.对印度 SARS-CoV-2 基因组进行全基因组分析,以鉴定遗传突变和单核苷酸多态性。
Infect Genet Evol. 2020 Nov;85:104457. doi: 10.1016/j.meegid.2020.104457. Epub 2020 Jul 11.
4
Polymorphic landscape of SARS-CoV-2 genomes isolated from Indian population in 2020 demonstrates rapid evolution in ORF3a, ORF8, nucleocapsid phosphoprotein and spike glycoprotein.2020 年从印度人群中分离的 SARS-CoV-2 基因组的多态性景观表明,ORF3a、ORF8、核衣壳磷酸蛋白和刺突糖蛋白快速进化。
Comput Biol Chem. 2021 Dec;95:107594. doi: 10.1016/j.compbiolchem.2021.107594. Epub 2021 Oct 26.
5
The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.新型 SARS-CoV-2 在全球传播六个月后的分子变异程度。
Infect Genet Evol. 2021 Jul;91:104800. doi: 10.1016/j.meegid.2021.104800. Epub 2021 Mar 5.
6
Genome-wide analysis of 10664 SARS-CoV-2 genomes to identify virus strains in 73 countries based on single nucleotide polymorphism.对 10664 个 SARS-CoV-2 基因组进行全基因组分析,基于单核苷酸多态性在 73 个国家识别病毒株。
Virus Res. 2021 Jun;298:198401. doi: 10.1016/j.virusres.2021.198401. Epub 2021 Mar 26.
7
Inferring the genetic variability in Indian SARS-CoV-2 genomes using consensus of multiple sequence alignment techniques.利用多重序列比对技术共识推断印度 SARS-CoV-2 基因组中的遗传变异。
Infect Genet Evol. 2020 Nov;85:104522. doi: 10.1016/j.meegid.2020.104522. Epub 2020 Sep 1.
8
Characterisation of SARS-CoV-2 clades based on signature SNPs unveils continuous evolution.基于特征 SNP 对 SARS-CoV-2 进化枝进行特征描述揭示了其持续进化。
Methods. 2022 Jul;203:282-296. doi: 10.1016/j.ymeth.2021.09.005. Epub 2021 Sep 20.
9
Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein and its consequences.SARS-CoV-2 核衣壳蛋白的进化动态及其后果。
J Med Virol. 2021 Apr;93(4):2177-2195. doi: 10.1002/jmv.26626. Epub 2020 Nov 10.
10
Phylogenetic and amino acid signature analysis of the SARS-CoV-2s lineages circulating in Tunisia.突尼斯流行的 SARS-CoV-2 谱系的系统发育和氨基酸特征分析。
Infect Genet Evol. 2022 Aug;102:105300. doi: 10.1016/j.meegid.2022.105300. Epub 2022 May 10.

引用本文的文献

1
Preclinical evaluation of ISH0339, a tetravalent broadly neutralizing bispecific antibody against SARS-CoV-2 with long-term protection.ISH0339的临床前评估,一种针对SARS-CoV-2的具有长期保护作用的四价广谱中和双特异性抗体。
Antib Ther. 2023 Mar 6;6(2):97-107. doi: 10.1093/abt/tbad003. eCollection 2023 Apr.
2
Unveiling the Biomarkers of Cancer and COVID-19 and Their Regulations in Different Organs by Integrating RNA-Seq Expression and Protein-Protein Interactions.通过整合RNA测序表达和蛋白质-蛋白质相互作用揭示癌症和新冠病毒病的生物标志物及其在不同器官中的调控。
ACS Omega. 2022 Nov 18;7(48):43589-43602. doi: 10.1021/acsomega.2c04389. eCollection 2022 Dec 6.
3
Bioinformatics pipeline unveils genetic variability to synthetic vaccine design for Indian SARS-CoV-2 genomes.生物信息学流程揭示了印度 SARS-CoV-2 基因组中与合成疫苗设计相关的遗传变异性。
Int Immunopharmacol. 2022 Nov;112:109224. doi: 10.1016/j.intimp.2022.109224. Epub 2022 Sep 6.
4
Human miRNAs to Identify Potential Regions of SARS-CoV-2.用于识别新型冠状病毒潜在区域的人类微小核糖核酸
ACS Omega. 2022 Jun 7;7(24):21086-21101. doi: 10.1021/acsomega.2c01907. eCollection 2022 Jun 21.
5
Phylogenetic analysis of 17271 Indian SARS-CoV-2 genomes to identify temporal and spatial hotspot mutations.对17271个印度新冠病毒基因组进行系统发育分析,以确定时空热点突变。
PLoS One. 2022 Mar 28;17(3):e0265579. doi: 10.1371/journal.pone.0265579. eCollection 2022.
6
Highlight of potential impact of new viral genotypes of SARS-CoV-2 on vaccines and anti-viral therapeutics.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)新病毒基因型对疫苗和抗病毒治疗潜在影响的亮点。
Gene Rep. 2022 Mar;26:101537. doi: 10.1016/j.genrep.2022.101537. Epub 2022 Feb 2.
7
Hotspot Mutations in SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)中的热点突变
Front Genet. 2021 Nov 29;12:753440. doi: 10.3389/fgene.2021.753440. eCollection 2021.
8
Characterisation of SARS-CoV-2 clades based on signature SNPs unveils continuous evolution.基于特征 SNP 对 SARS-CoV-2 进化枝进行特征描述揭示了其持续进化。
Methods. 2022 Jul;203:282-296. doi: 10.1016/j.ymeth.2021.09.005. Epub 2021 Sep 20.
9
Strategies for COVID-19 Epidemiological Surveillance in India: Overall Policies Till June 2021.印度 2021 年 6 月前的新冠肺炎疫情监测策略:总体政策
Front Public Health. 2021 Jul 22;9:708224. doi: 10.3389/fpubh.2021.708224. eCollection 2021.

本文引用的文献

1
Spike mutation D614G alters SARS-CoV-2 fitness.刺突突变 D614G 改变了 SARS-CoV-2 的适应性。
Nature. 2021 Apr;592(7852):116-121. doi: 10.1038/s41586-020-2895-3. Epub 2020 Oct 26.
2
Genome-wide analysis of Indian SARS-CoV-2 genomes for the identification of genetic mutation and SNP.对印度 SARS-CoV-2 基因组进行全基因组分析,以鉴定遗传突变和单核苷酸多态性。
Infect Genet Evol. 2020 Nov;85:104457. doi: 10.1016/j.meegid.2020.104457. Epub 2020 Jul 11.
3
SARS-CoV2 envelope protein: non-synonymous mutations and its consequences.SARS-CoV2 包膜蛋白:非同义突变及其后果。
Genomics. 2020 Nov;112(6):3890-3892. doi: 10.1016/j.ygeno.2020.07.001. Epub 2020 Jul 5.
4
Molecular conservation and differential mutation on ORF3a gene in Indian SARS-CoV2 genomes.印度 SARS-CoV-2 基因组中 ORF3a 基因的分子保守性和差异突变。
Genomics. 2020 Sep;112(5):3226-3237. doi: 10.1016/j.ygeno.2020.06.016. Epub 2020 Jun 12.
5
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.SARS-CoV-2 反向遗传学揭示了呼吸道感染的可变梯度。
Cell. 2020 Jul 23;182(2):429-446.e14. doi: 10.1016/j.cell.2020.05.042. Epub 2020 May 27.
6
COVID-19 target: A specific target for novel coronavirus detection.新冠病毒检测靶点:新型冠状病毒检测的特定靶点。
Gene Rep. 2020 Sep;20:100740. doi: 10.1016/j.genrep.2020.100740. Epub 2020 May 30.
7
Social network-based distancing strategies to flatten the COVID-19 curve in a post-lockdown world.基于社交网络的隔离策略,以在封锁后世界中拉平 COVID-19 曲线。
Nat Hum Behav. 2020 Jun;4(6):588-596. doi: 10.1038/s41562-020-0898-6. Epub 2020 Jun 4.
8
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.COVID-19 疾病患者和未接触者体内针对 SARS-CoV-2 冠状病毒的 T 细胞反应的靶标。
Cell. 2020 Jun 25;181(7):1489-1501.e15. doi: 10.1016/j.cell.2020.05.015. Epub 2020 May 20.
9
Overwhelming mutations or SNPs of SARS-CoV-2: A point of caution.SARS-CoV-2 压倒性的突变或单核苷酸多态性:值得警惕的一点。
Gene. 2020 Aug 20;752:144792. doi: 10.1016/j.gene.2020.144792. Epub 2020 May 20.
10
Viral dynamics in asymptomatic patients with COVID-19.无症状 COVID-19 患者的病毒动力学。
Int J Infect Dis. 2020 Jul;96:288-290. doi: 10.1016/j.ijid.2020.05.030. Epub 2020 May 11.